Kronik Pankreatitin Medikal Yönetimi
Özet
Kronik pankreatit; genetik, anatomik ve çevresel risk faktörlerine bağlı olarak gelişen, pankreas parankimi ve duktal sisteminde ilerleyici fibrozis, kalsifikasyon ve geri dönüşümsüz harabiyetle karakterize fibroinflamatuar bir sendromdur. Yıllık insansı 100.000 kişide 5-12 olan bu hastalık, çoğunlukla erkeklerde ve 35-45 yaş aralığında görülmektedir. Ağır alkol kullanımı ve sigara tüketimi en yaygın çevresel risk faktörleri olup, hastalar klinisyene en sık kronik karın ağrısı şikayetiyle başvurmaktadır. Teşhis süreci, hastanın klinik özellikleri ile bilgisayarlı tomografi (BT) ve manyetik rezonans görüntüleme (MRG) bulgularının kombinasyonuna dayanır. Hastalığın progresyonunu tamamen durduracak bir tıbbi tedavi henüz mevcut olmadığından, tedavi yönetimi semptomların hafifletilmesine, yaşam kalitesinin artırılmasına ve komplikasyonların erken yönetimine odaklanır. Ağrı kontrolünde Dünya Sağlık Örgütü'nün basamak tedavisi önerilmekte; bağımlılık riskini azaltmak amacıyla opioid olmayan analjezikler, antidepresanlar ve antikonvülsanlar öncelikli olarak tercih edilmektedir. Ekzokrin yetmezliğe bağlı gelişen malabsorpsiyon, diyare ve steatoreyi kontrol altına almak amacıyla pankreatik enzim replasman ve beslenme tedavileri uygulanır. Medikal tedavinin yetersiz kaldığı darlık ve taş gibi kanal tıkanıklığı durumlarında ise intraduktal basıncı ve ağrıyı azaltmak amacıyla ERCP gibi endoskopik girişimler veya parsiyel rezeksiyon ve drenajı içeren cerrahi prosedürler uygulanmaktadır.
Chronic pancreatitis is a progressive fibroinflammatory syndrome driven by genetic, anatomic, and environmental factors, leading to irreversible destruction, fibrosis, and calcification of the pancreatic parenchyma and ductal system. With an annual incidence of 5-12 per 100,000 individuals, it predominantly affects males between the ages of 35 and 45. Heavy alcohol use and smoking represent the primary environmental risk factors, and patients most frequently present with severe chronic abdominal pain. Diagnosis is established by combining clinical presentations with characteristic findings from computed tomography (CT) and magnetic resonance imaging (MRI). Because no current medical therapy can halt or reverse the progression of the disease, management primarily targets symptom palliation, quality of life improvement, and the early mitigation of secondary complications. Pain management strictly follows the World Health Organization's analgesic ladder, prioritizing non-opioid medications, antidepressants, and anticonvulsants to minimize opioid reliance. Furthermore, pancreatic enzyme replacement and nutritional therapies are optimized to manage malabsorption, diarrhea, and steatorrhea secondary to exocrine insufficiency. When conservative medical approaches fail to relieve ductal obstructions caused by strictures or stones, endoscopic interventions such as ERCP or surgical procedures incorporating partial resection and drainage are utilized to alleviate intraductal hypertension and pain.
Referanslar
Mann R, Boregowda U, Vyas N, et al. Current advances in the management of chronic pancreatitis. Dis Mon. 2021; 24:101225. doi: 10.1016/j.disamonth.2021.101225.
Singh VK, Yadav D, Garg PK. Diagnosis and Management of Chronic Pancreatitis: A Review. JAMA. 2019;322(24):2422-2434. doi:10.1001/jama.2019.19411
Patel V, Willingham F. The Management of Chronic Pancreatitis. Med Clin North Am. 2019;103(1):153-162. doi:10.1016/j.mcna.2018.08.012
Drewes AM, Bouwense SAW, Campbell CM, et al. Guidelines for the understanding and management of pain in chronic pancreatitis. Pancreatology. 2017;17(5):720-731. doi:10.1016/j.pan.2017.07.006
Beyer G, Habtezion A, Werner J, et al. Chronic pancreatitis. Lancet. 2020;396(10249):499-512. doi: 10.1016/S0140-6736(20)31318-0
Kleeff J, Whitcomb DC, Shimosegawa T, et al. Chronic pancreatitis. Nat Rev Dis Primers. 2017;3:17060. doi: 10.1038/nrdp.2017.60
Kichler A, Jang S. Chronic Pancreatitis: Epidemiology, Diagnosis, and Management Updates. Drugs. 2020;80(12):1155-1168. doi:10.1007/s40265-020-01360-6
O'Brien SJ, Omer E. Chronic Pancreatitis and Nutrition Therapy. Nutr Clin Pract. 2019;34 Suppl 1:S13-S26. doi: 10.1002/ncp.10379.
Gardner TB, Adler DG, Forsmark CE, et al. ACG Clinical Guideline: Chronic Pancreatitis. Am J Gastroenterol. 2020;115(3):322-339. doi: 10.14309/ajg.0000000000000535.
Majumder S, Chari ST. Chronic pancreatitis. Lancet. 2016;387(10031):1957-66. doi: 10.1016/S0140-6736(16)00097-0.
Löhr JM, Dominguez-Munoz E, Rosendahl J, et al. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J. 2017;5(2):153-199. doi:10.1177/2050640616684695
Rahman A, O'Connor DB, Gather F, et al. Clinical Classification and Severity Scoring Systems in Chronic Pancreatitis: A Systematic Review. Dig Surg. 2020;37(3):181-191. doi:10.1159/000501429
Schneider A, Löhr JM, Singer MV. The M-ANNHEIM classification of chronic pancreatitis: introduction of a unifying classification system based on a review of previous classifications of the disease. J Gastroenterol. 2007;42(2):101-119. doi:10.1007/s00535-006-1945-4
Beyer G, Mahajan UM, Budde C, et al. Development and Validation of a Chronic Pancreatitis Prognosis Score in 2 Independent Cohorts. Gastroenterology. 2017;153(6):1544-1554.e2. doi:10.1053/j.gastro.2017.08.073
Drewes AM, Olesen AE, Farmer AD, Szigethy E, Rebours V, Olesen SS. Gastrointestinal pain. Nat Rev Dis Primers. 2020;6(1):1. Published 2020 Jan 6. doi:10.1038/s41572-019-0135-7
Shrikhande SV, Martignoni ME, Shrikhande M, et al. Comparison of histological features and inflammatory cell reaction in alcoholic, idiopathic and tropical chronic pancreatitis. Br J Surg. 2003;90(12):1565-1572. doi:10.1002/bjs.4353
Machicado JD, Chari ST, Timmons L, et al. A population-based evaluation of the natural history of chronic pancreatitis. Pancreatology. 2018;18(1):39-45. doi:10.1016/j.pan.2017.11.012
Gupta V, Toskes PP. Diagnosis and management of chronic pancreatitis. Postgrad Med J. 2005;81(958):491-497. doi:10.1136/pgmj.2003.009761
Valente R, Waldthaler A, Scandavini CM, et al. Conservative Treatment of Chronic Pancreatitis: A Practical Approach. Scand J Surg. 2020;109(1):59-68. doi:10.1177/1457496920905559
Juel J, Olesen SS, Olesen AE, et al. Study protocol for a randomised, double-blinded, placebo-controlled, clinical trial of S-ketamine for pain treatment in patients with chronic pancreatitis (RESET trial). BMJ Open. 2015;5(3):e007087. Published 2015 Mar 10. doi:10.1136/bmjopen-2014-007087
Kaufman M, Singh G, Das S, et al. Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer.J Clin Gastroenterol. 2010;44(2):127-134. doi:10.1097/MCG.0b013e3181bb854d
Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation.JAMA. 1995;274(23): 1870-1873. doi:10.1001/jama.1995.03530230056031
Cahen DL, Gouma DJ, Nio Y, et al. Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis. N Engl J Med. 2007;356(7):676-84. doi: 10.1056/NEJMoa060610
Yoo BM, Lehman GA. Update on endoscopic treatment of chronic pancreatitis. Korean J Intern Med. 2009;24(3):169-179. doi:10.3904/kjim.2009.24.3.169
Morton JM, Brown A, Galanko JA, Norton JA, Grimm IS, Behrns KE. A national comparison of surgical versus percutaneous drainage of pancreatic pseudocysts: 1997-2001. J Gastrointest Surg. 2005;9(1):15-21. doi:10.1016/j.gassur.2004.10.005
